IRONWOOD PHARMACEUTICALS, INC.

IRWD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-73.3M
Depreciation & Amortization $4.8M
Depreciation
Amortization
Stock-Based Compensation $5.1M
Net Cash from Operating Activities $-3.4M
Investing Activities
Capital Expenditures $3.5M
Business Acquisitions
Net Cash from Investing Activities $17.8M
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $41.7M
Net Change in Cash $56.0M
Free Cash Flow $-7.0M
← Newer Page 3 of 3 Older →